Follow
Calvin Gordon
Calvin Gordon
Graduate Student, University of Alberta
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
CJ Gordon, EP Tchesnokov, E Woolner, JK Perry, JY Feng, DP Porter, ...
Journal of Biological Chemistry 295 (20), 6785-6797, 2020
9602020
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
CJ Gordon, EP Tchesnokov, JY Feng, DP Porter, M Götte
Journal of Biological Chemistry 295 (15), 4773-4779, 2020
9582020
Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
CJ Gordon, EP Tchesnokov, RF Schinazi, M Götte
Journal of Biological Chemistry 297 (1), 2021
2752021
Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
EP Tchesnokov, CJ Gordon, E Woolner, D Kocinkova, JK Perry, JY Feng, ...
Journal of Biological Chemistry 295 (47), 16156-16165, 2020
1432020
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
LJ Stevens, AJ Pruijssers, HW Lee, CJ Gordon, EP Tchesnokov, J Gribble, ...
Science translational medicine 14 (656), eabo0718, 2022
1232022
Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir
CJ Gordon, HW Lee, EP Tchesnokov, JK Perry, JY Feng, JP Bilello, ...
Journal of Biological Chemistry 298 (2), 2022
302022
Evolution of naturally arising SARS-CoV-2 defective interfering particles
S Girgis, Z Xu, S Oikonomopoulos, AD Fedorova, EP Tchesnokov, ...
Communications Biology 5 (1), 1140, 2022
172022
Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs
K Maheden, B Todd, CJ Gordon, EP Tchesnokov, M Götte
The Enzymes 49, 315-354, 2021
112021
The nucleoside/nucleotide analogs tenofovir and emtricitabine are inactive against SARS-CoV-2
JY Feng, V Du Pont, D Babusis, CJ Gordon, EP Tchesnokov, JK Perry, ...
Molecules 27 (13), 4212, 2022
102022
Distinct genetic determinants and mechanisms of SARS-CoV-2 resistance to remdesivir
LJ Stevens, AJ Pruijssers, HW Lee, CJ Gordon, EP Tchesnokov, J Gribble, ...
BioRxiv, 2022.01. 25.477724, 2022
42022
NRTIs tenofovir, TAF, TDF, and FTC are inactive against SARS-CoV-2
JY Feng, JP Bilello, D Babusis, CJ Gordon, EP Tchesnokov, JK Perry, ...
Communications 11, 5214, 2020
32020
Mechanism and spectrum of inhibition of a 4′-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses
CJ Gordon, SM Walker, EP Tchesnokov, D Kocincova, J Pitts, DS Siegel, ...
bioRxiv, 2024.04. 22.590607, 2024
2024
Distinct genetic determinants and mechanisms of SARS-CoV-2 resistance to remdesivir (preprint)
LJ Stevens, AJ Pruijssers, HW Lee, CJ Gordon, EP Tchesnokov, J Gribble, ...
2022
The system can't perform the operation now. Try again later.
Articles 1–13